SVB Leerink Downgrades Amneal Pharmaceuticals (AMRX) to Market Perform
Tweet
Share
E-mailGet Alerts AMRX Hot Sheet
Price: $18.15 +5.10%
Rating Summary:
6 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
6 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
SVB Leerink analyst Ami Fadia downgraded Amneal Pharmaceuticals (: AMRX) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on Amneal Pharmaceuticals click here. For more ratings news on Amneal Pharmaceuticals click here.
Shares of Amneal Pharmaceuticals closed at $1.75 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RBC Capital Downgrades Accelerant Holdings (ARX) to Sector Perform
- DA Davidson Downgrades Blaize Inc. (BZAI) to Neutral
- Axis Capital Limited Downgrades Tata Motors Passenger Vehicles (TMPV:IN) to Sell (4)
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
